- Report
- March 2022
- 124 Pages
Global
From €5432EUR$5,500USD£4,520GBP
- Report
- June 2021
- 252 Pages
Global
From €2716EUR$2,750USD£2,260GBP
€5432EUR$5,500USD£4,520GBP
- Report
- September 2023
- 167 Pages
Global
From €4593EUR$4,650USD£3,821GBP
- Report
- July 2023
- 152 Pages
Global
From €4593EUR$4,650USD£3,821GBP
- Report
- March 2023
- 151 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- February 2023
- 127 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- January 2023
- 45 Pages
Global
From €2469EUR$2,500USD£2,054GBP
- Report
- November 2022
- 68 Pages
Global
From €3457EUR$3,500USD£2,876GBP
- Report
- October 2022
- 147 Pages
Global
From €5432EUR$5,500USD£4,520GBP
- Report
- October 2022
- 99 Pages
Global
From €5432EUR$5,500USD£4,520GBP
- Report
- July 2022
- 93 Pages
Global
From €5432EUR$5,500USD£4,520GBP
- Report
- April 2022
- 114 Pages
Global
From €5432EUR$5,500USD£4,520GBP
- Report
- February 2022
- 312 Pages
Global
From €2963EUR$3,000USD£2,465GBP
- Report
- January 2022
- 228 Pages
Global
From €2716EUR$2,750USD£2,260GBP
€5432EUR$5,500USD£4,520GBP
- Report
- October 2021
- 178 Pages
Global
From €2716EUR$2,750USD£2,260GBP
€5432EUR$5,500USD£4,520GBP
- Report
- September 2021
- 195 Pages
Global
From €2716EUR$2,750USD£2,260GBP
€5432EUR$5,500USD£4,520GBP
- Report
- May 2021
- 174 Pages
Global
From €1358EUR$1,375USD£1,130GBP
€2716EUR$2,750USD£2,260GBP
- Report
- April 2021
- 145 Pages
Global
From €1358EUR$1,375USD£1,130GBP
€2716EUR$2,750USD£2,260GBP
- Report
- April 2021
- 302 Pages
Global
From €1358EUR$1,375USD£1,130GBP
€2716EUR$2,750USD£2,260GBP
- Report
- March 2021
- 99 Pages
Global
From €1358EUR$1,375USD£1,130GBP
€2716EUR$2,750USD£2,260GBP
The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more